Biogen Inc. (BIIB)
Market Closed
16 Oct, 08:00 PM
$
232. 65
-2.7
-1.1472%
$
33.35B Market Cap
24.69 P/E Ratio
- Div Yield
1.46M Volume
14.99 Eps
$ 235.35
Previous Close 
Want to track BIIB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biogen and Ionis Pharma shares slide as they end development of ALS treatment
The stocks of Biogen Inc. and Ionis Pharmaceuticals Inc. were lower Thursday, after the partners said they were terminating development of a treatment for the fatal disease Amyotrophic Lateral Sclerosis, or ALS, after a disappointing trial.
Marketwatch | 2 years ago
2026 © Marketlog. All Rights Reserved.
